Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. - Wikidata - wikimedia - TriplyDB

Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.

Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.

http://www.wikidata.org/entity/Q34104256

about

Anticholinergic medication use and dementia: latest evidence and clinical implications Mirabegron in overactive bladder patients: efficacy review and update on drug safety Assessment of cognitive safety in clinical drug development Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis Antidepressant use and cognitive decline in community-dwelling elderly people - The Three-City Cohort CUA guideline on adult overactive bladder Turning over the rocks: role of anticholinergics and benzodiazepines in cognitive decline and falls.The potential applications of Apolipoprotein E in personalized medicine An update on the diagnosis and management of dementing conditions Use of anticholinergics and the risk of cognitive impairment in an African American population Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors.Caffeine, cognitive functioning, and white matter lesions in the elderly: establishing causality from epidemiological evidence.Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review.Agitation and Irritability in Alzheimer's Disease: Evidenced-Based Treatments and the Black-Box Warning.Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline.Cognitive decline in older persons initiating anticholinergic medications.Donepezil plus estradiol treatment enhances learning and delay-dependent memory performance by young ovariectomized rats with partial loss of septal cholinergic neurons Medication management for people with dementia in primary care: description of implementation in the DelpHi study.Treating overactive bladder in the elderly.Anticholinergic drugs and their effects on delirium and mortality in the elderly.Use of CNS medications and cognitive decline in the aged: a longitudinal population-based study Drug-induced cerebral glucose metabolism resembling Alzheimer's Disease: a case study.Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease.The greater sensitivity of elderly APOE ε4 carriers to anticholinergic medications is independent of cerebrovascular disease risk Antidepressant Use and Cognitive Decline: The Health and Retirement Study Long-term anticholinergic use and the aging brain.Use of Medicines with Anticholinergic and Sedative Effect Before and After Initiation of Anti-Dementia Medications.How Prolific is Psychotropic Medicines Use in People with Dementia in Australia Within the Community Setting? A Retrospective Analysis.An Update on Geriatric Medication Safety and Challenges Specific to the Care of Older Adults.Lipid lowering agents, cognitive decline, and dementia: the three-city study.Managing polypharmacy in a 77-year-old woman with multiple prescribers.Sleep disturbances and driving practices of older drivers.Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults Over-Prescribed Medications, Under-Appreciated Risks: A Review of the Cognitive Effects of Anticholinergic Medications in Older Adults.Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem.Long-term cognitive and functional effects of potentially inappropriate medications in older women.Falls risk reduction and treatment of overactive bladder symptoms with antimuscarinic agents: a scoping review.Drugs with anticholinergic properties: a current perspective on use and safety.

P2860

Q28068339-AC310693-0214-4023-82DB-873870362727 Q28072230-8D6AF1F1-7B22-4A52-9796-6AC7F5C0E849 Q28084637-774AC21E-4841-4440-98B1-7449FFA83954 Q28085414-3804AD60-A75D-4A06-AE4B-238E002F9DF7 Q28255929-AEBFBB24-5F60-412D-BBF3-F90C8A8A72BC Q28258219-9C69F66E-DF13-4A37-A711-E00225B748C5 Q33582388-70DA8558-8CF6-4217-8D1F-B88509C05BB3 Q33665026-405650D2-C128-43FD-9A33-73F1A17D416B Q33715169-A56BDDA4-E23B-4C82-B01E-D78E6C92A4C3 Q33858831-8505F9D4-CC7B-45F3-A153-68328E225BCA Q33896147-42491A43-52B8-48A1-974A-2263E38C67FF Q34002967-4E1896C9-10DA-4A37-8217-303113257412 Q34047968-FB317A24-4886-48F7-A0DF-57B98BDBAE6E Q34088937-2757D36A-D2B3-4CED-837E-8188D9EF1EB8 Q34429787-B1AA3F78-5E42-4B04-AD06-DBBC22181393 Q34506252-7C1840B6-95C9-468E-8DBD-9F8C579C1096 Q34521956-08B83BFC-F89D-469E-9A97-A787AE5F4822 Q34760402-89F4011C-2967-4ACA-A999-AAA8A30246D1 Q34842990-E8BA4B55-4E11-4954-A80C-FF417FD4ACB4 Q35041890-2897DFD8-E04B-4DD1-B02E-8B6C186C9B00 Q35347702-640EC0AB-E3DC-42BB-ABB9-68E56ACF4B8C Q35428172-9EF9E186-1D21-432E-B4AE-9C999C2807F7 Q35580037-2B3F3E80-28E0-474C-807D-FAAE62147868 Q35688580-A80E0A5A-5ABC-4E3A-8876-C8BDB633DAA9 Q35944999-EEEEE94B-AF13-4E42-BF95-1BBD37B5A62A Q36007813-E1EF4572-D6BE-4754-8F0A-C2F61B4CBFC2 Q36201714-1A4CFBCD-DF64-47BB-81A3-A82BB665B1A7 Q36906645-103F6EEF-FD57-4950-AA28-C12798D2F422 Q36942845-D7D8BFB5-EDF9-48AB-B9D6-41D9C2D6FE21 Q36942933-32A117B6-B46E-4A64-911B-40C13029CF07 Q37025156-BD067DEF-C111-492D-B035-9C564B248D23 Q37095998-1198B8D6-971C-443A-BE38-91564713F830 Q37207700-3CEB7B28-4209-4760-9E3E-4BB126D2E9EA Q37230913-1727144C-28EB-4824-A0C4-3F969482D249 Q37268405-E7D7657B-328A-439B-A599-66842870A9BC Q37446075-E9B4DF07-1FE9-43DC-8EB9-089E1DFA3CE4 Q37632244-3A824124-5B1D-4955-9E5F-204A71E63DE8 Q37670854-1F6DDD4C-9B51-4DD9-93B3-46C9D2393AF1 Q37831263-1849887D-C52D-432E-9514-3B8027C0EAE5 Q37884068-2E6EF210-5F35-4AAE-9532-53AF887E13FB

P2860

Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.

http://www.wikidata.org/entity/Q34104256

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Drugs with anticholinergic pro ...... population: the 3-city study.

@ast

Drugs with anticholinergic pro ...... population: the 3-city study.

@en

Drugs with anticholinergic pro ...... population: the 3-city study.

@nl

type

label

Drugs with anticholinergic pro ...... population: the 3-city study.

@ast

Drugs with anticholinergic pro ...... population: the 3-city study.

@en

Drugs with anticholinergic pro ...... population: the 3-city study.

@nl

prefLabel

Drugs with anticholinergic pro ...... population: the 3-city study.

@ast

Drugs with anticholinergic pro ...... population: the 3-city study.

@en

Drugs with anticholinergic pro ...... population: the 3-city study.

@nl

P1433

Q34104256-3E24D802-FAF1-437E-BB7C-522C5F01AB3D

P1476

Q34104256-B49CCCB6-7D57-43B3-8548-15532E1A55F2

P2093

Q34104256-0344E1D5-ED71-4612-A68F-9EEADF69CDF7

Q34104256-5209F631-AC63-44EA-999D-A2689E425297

Q34104256-90EE2218-255D-49A4-B25F-6C1CC4297213

Q34104256-9A654FEC-2F60-4696-8BB2-05DF0E3882CF

Q34104256-DB8CC9AC-4649-423A-88ED-DA9C5EE501DB

P2860

Q34104256-0BC27652-D9D9-490A-94BA-2D61456C1483

Q34104256-0C899D05-9976-4CA8-A186-9731327B2CA1

Q34104256-0D703EA8-186E-4834-8C53-08F5BB56219B

Q34104256-16528B38-6B57-4481-8851-4EE51410E3A9

Q34104256-1A549FC4-CA4C-4DDC-9042-B6F01EF0E28D

Q34104256-1FB60F02-30EC-42BE-8C8E-86B14E448FAF

Q34104256-37970D05-BBDA-4C38-9C01-6F9B13DC2FEE

Q34104256-3A1AC415-0C8C-4F8D-BF04-DC80BEE46A39

Q34104256-3FB833F4-4FA6-4FB9-99C3-D7AF4311D9EA

Q34104256-45156231-65E7-4A1E-B333-45C932579207

P304

Q34104256-16B52CE5-CB26-4575-8A29-455FF94D9668

P31

Q34104256-8F9B13D0-AC4C-4498-B282-850A62BE7EAA

P356

Q34104256-FB084186-927E-4EC8-9DA1-79EB08FA7DD5

P407

Q34104256-1934603D-17BB-4C95-9840-412FA7DC25C4

P433

Q34104256-09B92051-D318-4EF2-BAF3-024FC4CEA0F0

P478

Q34104256-DF9CCF5C-EDBC-4629-AABC-60D9AE472C97

P50

Q34104256-B58BE01E-5C0C-46A0-9F14-B9588D4AEF47

Q34104256-E6839E46-0AB1-44CD-A778-2C3147A40C9E

P577

Q34104256-E8131668-25AB-48E7-BCE6-A8C25291C972

P5875

Q34104256-B065AEC1-E1B6-4DD4-9EE5-68C2AEFB0D79

P698

Q34104256-2F7C247E-749B-4301-950E-4DC4516B0518

P932

Q34104256-1F8E9EEB-ECFE-423B-BFA2-AA9D9F789C18

P356

ARCHINTERNMED.2009.229

P1433

JAMA Internal Medicine

P1476

Drugs with anticholinergic pro ...... l population: the 3-city study

@en

P2093

Annie Fourrier-Reglat

http://www.w3.org/2001/XMLSchema#string

Isabelle Carrière

http://www.w3.org/2001/XMLSchema#string

Jean-François Dartigues

http://www.w3.org/2001/XMLSchema#string

Karen Ritchie

http://www.w3.org/2001/XMLSchema#string

Olivier Rouaud

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Pharmacodynamics in older adults: a review.

Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study.

Drug-induced cognitive impairment in the elderly.

Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study

Hypersensitivity to scopolamine in the elderly.

Potentially reversible conditions in 1000 consecutive memory clinic patients.

M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy.

Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study

Optimising drug treatment for elderly people: the prescribing cascade

P304

1317-1324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHINTERNMED.2009.229

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

169

http://www.w3.org/2001/XMLSchema#string

P50

Florence Pasquier

Marie-Laure Ancelin

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26699054

http://www.w3.org/2001/XMLSchema#string

P698

19636034

http://www.w3.org/2001/XMLSchema#string

P932

2933398

http://www.w3.org/2001/XMLSchema#string